These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 19998200
1. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials. Rennie S, Stürmer T. Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200 [No Abstract] [Full Text] [Related]
2. Research, medicine, and "placebos". Moerman DE. Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201 [No Abstract] [Full Text] [Related]
3. Conflating scientific with clinical considerations. van der Graaf R, van Delden JJ. Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198 [No Abstract] [Full Text] [Related]
4. A clinical perspective on placebo research: looking back, looking forward. Dworkin RW. Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196 [No Abstract] [Full Text] [Related]
5. Who's in control of the choice of control? Anderson JA. Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199 [No Abstract] [Full Text] [Related]
6. Ethical issues in the difference between placebo-controlled and active-controlled trials. Petrini C. Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197 [No Abstract] [Full Text] [Related]
7. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials. Howick J. Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192 [Abstract] [Full Text] [Related]
8. Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries. Howick J. Am J Bioeth; 2009 Sep; 9(9):W5-7. PubMed ID: 19998178 [No Abstract] [Full Text] [Related]
9. The rationale for placebo-controlled trials: methodology and policy considerations. Miller FG. Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193 [No Abstract] [Full Text] [Related]
10. Distinguishing dilemmas in the ethics of placebo-controlled trials. Kovach K. Am J Bioeth; 2002 Sep; 2(2):32-3. PubMed ID: 12189072 [No Abstract] [Full Text] [Related]
11. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research. Orentlicher D. Hastings Cent Rep; 2005 Sep; 35(5):20-8. PubMed ID: 16295261 [Abstract] [Full Text] [Related]
12. I thought we were in this together? Trachtman H. Am J Bioeth; 2002 Sep; 2(2):30-1. PubMed ID: 12189071 [No Abstract] [Full Text] [Related]
13. Placebo misconceptions. Senn S. Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195 [No Abstract] [Full Text] [Related]
14. The physician/investigator's obligation to patients participating in research: the case of placebo controlled trials. Glass KC, Waring D. J Law Med Ethics; 2005 Sep; 33(3):575-85. PubMed ID: 16240737 [No Abstract] [Full Text] [Related]
16. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials. Nunn R. Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194 [No Abstract] [Full Text] [Related]
17. When do the federal regulations allow placebo-controlled trials in children? Miller FG, Wendler D, Wilfond B. J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527 [No Abstract] [Full Text] [Related]
18. What makes placebo-controlled trials unethical? Miller FG, Brody H. Am J Bioeth; 2002 Feb; 2(2):3-9. PubMed ID: 12189059 [Abstract] [Full Text] [Related]
19. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution. Golomb BA. Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203 [No Abstract] [Full Text] [Related]